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Biosensorsresearchisafastgrowingfieldinwhichtensofthousandsofpapershavebeenpublishedovertheyears,andtheindustry
is now worth billions of dollars. The biosensor products have found their applications in numerous industries including food
and beverages, agricultural, environmental, medical diagnostics, and pharmaceutical industries and many more. Even though
numerous biosensors have been developed for detection of proteins, peptides, enzymes, and numerous other biomolecules for
diverse applications, their applications in tissue engineering have remained limited. In recent years, there has been a growing
interestinapplicationofnovelbiosensorsincellcultureandtissueengineering,forexample,real-timedetectionofsmallmolecules
such as glucose, lactose, and H2O2 as well as serum proteins of large molecular size, such as albumin and alpha-fetoprotein, and
inflammatorycytokines,suchasIFN-gandTNF-𝗼.Inthisreview,weprovideanoverviewoftherecentadvancementsinbiosensors
for tissue engineering applications.
1. Introduction
Biosensors have gained enormous attention in recent years
in medicine and nanotechnology, and there is a growing
interest in its application in tissue engineering. Since the
developmentofthefirstoxygenbiosensorbyLelandClarkin
1962 [1], researchers in diverse fields have developed numer-
ous biosensors for applications in medicine, biotechnology,
and defense against bioterrorism, as well as foods, beverages,
and environmental and agricultural applications [2].
Recently, biosensors have shown immense potential for
applicationsintissueengineeringandregenerativemedicine.
Both tissue engineering and regenerative medicine are
rapidly growing fields in biomedical engineering presenting
enormous potential for development of engineered tissue
constructs for restoring the lost functions of diseased or
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damaged tissues and organs [3, 4]. Biosensors are gradually
becoming an integral part of such tissue engineering systems
particularlyinmicrofluidictissueengineeringmodelsasthey
can sense specific biological molecules within the miniatur-
ized tissue constructs in real-time, at very low concentration
levels, through ultrasensitive optical, electrochemical, or
acoustic sensing systems. The most frequent use of biosen-
sors so far has been in blood glucose monitoring [5, 6].
Enzymes, antibodies, and receptors have been widely used
in biosensors as biological sensing elements [7]. Biosensors
have also shown potential for in vivo sensing of disease-
specific biomarkers[8]. Thedevice in an in vivo environment
can monitor real-time biological signals, such as the release
of proteins or antibodies in response to tissue damage,
muscular dystrophy, cardiac infarction, inflammatory events
or infections. Thus biosensors possess a unique advantage
to inform health-related complexities in a timely manner
which is a powerful tool for early stage disease detection and
treatment in clinical settings [9].
To precisely sense the biological signals in a cellular
microenvironment,aprobewithmicro-ornano-dimensions
is desirable. For this purpose, sensors with nanoscale dimen-
sions, such as nanotubes or nanowires, have been developed
foreffectivebiosensinganddiagnosticspurposes.Theycanbe
used to measure pH or functionalized with specific capture
molecules to identify very low quantities of biological and
chemicalspecies[9]. For example, nanocantilevers were used
to monitorthe serum protein marker levels and to determine
the content of specific DNA moieties [10, 11]. Quantum dots,
which are highly fluorescent semiconductor nanocrystals,
c a na l s ob eu s e dt od e t e c ts p e c i fi cp r o t e i no rD N A[ 12].
In fact, research is in progress to use nanobiosensors in
combination with signaling and therapeutic delivery devices
for in vivo screening and treatment [13–15]. Interestingly,
biosensorswithdifferentmicro-andnanostructuredsurfaces
have been successfully used for both short-term and long-
term in vivo studies [16]. The sensors were biocompatible
and demonstrated increased biointegration, adhesion, pro-
liferation, differentiation, and signaling potentials. To date,
theapplicationofbiosensorsinbiomedicalengineeringisstill
limitedandisatitsearlystageofdevelopment.Y et,theclinical
potential can be realized. However, the combination of these
two multidisciplinary technologies offers great promise for
theireventualtranslationfrombenchtobed-sideapplications
i nt h en e a rf u t u r e .Th eo b j e c t i v eo ft h i sr e v i e wi st op r e s e n t
a comprehensive overview of the fundamental principles
for biosensor design, fabrication, and operation mechanisms
and to provide insights to their rapidly growing and future
potentials in the field of biomedical engineering, particularly
with respect to tissue engineering.
2. Fundamentals of Biosensors
2.1. Definition and Types of Biosensors. Ab i o s e n s o rc a nb e
defined as “a self-contained analytical device that combines
a biological component with a physicochemical component
for the detection of an analyte of biological importance.” It is
typically comprised of three fundamental components, such
as (a) a detector to detect the stimulus, (b) a transducer
to convert the stimulus to output signal, and (c) a signal
processing system to process the output and present it in an
appropriate form, Figure 1.
Biosensors can be classified into different types either
based on their sensing components or the transducer com-
ponents as described below.
2.2. Bioreceptors or Biosensing Components. The biosensing
components of biosensors can be divided into two types,
namely, catalytic type and affinity type. The catalytic type
sensors include enzymes, microbes, organelles, cells, or tis-
sues, while the affinity type includes antibodies, receptors,
and nucleic acids. Some of the important ones among these
types are discussed below.
2.2.1. Enzymes. The enzymes used as bioreceptor compo-
nents in biosensors are usually proteins of oxidase type that
canselectivelyreactwithspecificanalytes,consumedissolved
O2,andproduceH 2O2 thatisaneasilydetectablecompound.
O t h e rm e c h a n i s m so fe n z y m eb a s e db i o s e n s i n gi n c l u d et h e
detection of enzyme activation or inhibition by the analyte
andthemodificationoftheenzymepropertiesbytheanalyte.
The enzyme molecules can be directly immobilized on the
transducer surfaces using entrapment in gels, attachment
through covalent bonding, physical adsorption on the sur-
faces,orotheravailabletechniques[17,18].Theadvantagesof
enzyme based biosensing include the commercial availability
of enzymes at high purity level, the high specificity of their
binding capabilities, the suitability with various transduction
techniques, and the ability to detect a wide range of analytes.
Besides,sincetheactionmechanismofenzymesisofcatalytic
nature where the enzyme itself remains unaltered at the
end of the reaction, these sensors can be used continuously.
The disadvantages of the enzyme based sensors include the
limited stability of the enzymes and the dependency of
their activities on various factors such as pH, ionic strength,
chemical inhibition, and temperature.
2.2.2. Microbes. Th eu s eo fm i c r o b e sh a san u m b e ro fa d v a n -
tages as biological sensing component in the production of
biosensors.Theyarepresen talloverandha veagrea tca pacity
to acclimatize to undesirable conditions and to develop the
abilitytometabolizenewmoleculeswithtime.Microbialcells
are cheaper than enzymes or antibodies. They can carry out
several complex reactions while maintaining their stability.
W h o l ec e l l sc a nb eu s e de i t h e ri nav i a b l eo rn o n v i a b l e
form.Viablecellshavegainedimportanceinthemanufacture
of biosensors and these cells metabolize various organic
compounds either anaerobically or aerobically resulting in
various end products like ammonia, carbon dioxide, acids,
and so forth that can be monitored using a variety of
transducers. The use of microbial biosensors is common in
environmental fields that include the detection of harmful
bacteria or pesticides in air, water, or food and biological
oxygen demand [19–21].BioMed Research International 3
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Figure1:Schematicrepresentationoftheworkingprincipleofbiosensors:(a)interactionbetweentissue,interphase,andbiosensors.Figure 1
is reproduced with courtesy of http://www.tankonyvtar.hu/. (b) The components involved in biosensing.
2.2.3. Organelles. The compartments located inside the cells
areknownasorganelles.Eachoftheorganelleshasindividual
functions such as lysosome, chloroplast, and mitochondria.
Mitochondria are responsible for calcium metabolism and
controllingthecalciumdependentpathwaysincells.Previous
studiesprovedthatpresenceofhighconcentrationofcalcium
s t i m u l a t e st h em i t o c h o n d r i at oo p e nt h ec a l c i u mc h a n n e l s .
This bioinspired strategy can be used to measure calcium
concentration in medium. Application of mitochondria for
water pollution detection is another application of organelles
in biosensor [22].
2.2.4. Cells and Tissues. C e l l sh a v eb e e no ft e nu s e di n
bioreceptors because they have high sensitivity to adjacent
environment. The attachment on the surface is the main
characteristic of cells, so they can be easily immobilized.
They are frequently used to detect global parameter like
stress condition, toxicity, and organic derivatives and to
monitor the treatment effect of drugs. Cells were also used
in ion selective transducers [23, 24]. Tissues are also used
in biosensors as they contain large quantity of enzymes.
They offer a number of advantages over cells and organelles
such as, easier immobilization, higher activity and stability,
low price, and existence of necessary cofactors to function
[25]. Their disadvantages include lack of specificity because
of the presence of undesirable enzymes which can make
the reaction complicated and result in ambiguous and less
reliable outputs.
2.2.5. Antibodies. Antibodies are proteins produced by B-
Lymphocytes in response to antigenic stimulation. The anti-
body based sensors are also known as immunosensors.4 BioMed Research International
Usually, antibodies are used in surface plasmon resonance
(SPR) biosensors to design target specific sensors for detect-
ing specific biomolecules. This is a simple mechanism that
works through antigen-antibody interaction process. The
antibodies are usually linked to the surface of transducers
through covalent bonds such as amide, ester, or thiol bonds.
The transducer surface needs to be modified by polymers
or monomers to introduce functional groups such as car-
boxyl, amino, aldehyde, or sulfhydryl groups to facilitate
conjugation between the antibody and transducer. To date,
many antibodies have been made available in the market
a n du s e di ni m m u n o a s s a y s .Th e ya r em o r ea c c u r a t ea n d
fastercomparedtothetraditionalassays[26].However,there
are some limitations for antibody based biosensors, such as
the irreversible interaction and the strength of the binding
affinity. Thelatter is dependent onconditionssuch aspH and
temperature, making the results highly variable due to the
measurement conditions [27, 28].
2.2.6. Nucleic Acids. Oligonucleotides integrate in nucleic
acid biosensor with a signal transducer. Oligonucleotide
probe is immobilized on the transducer to detect DNA/RNA
fragments.Thedetectionprocessisbasedonthecodeofcom-
plementary nucleotide base pairing, adenine (A): thymine
(T)andcytosine(C):guanine(G)inDNA.Thehybridization
probes in the sensor can then base pair with the target
sequences and create an optical signal [27].
2.3. Biotransducer Components. The transducer component
of biosensors can be grouped into different types such as
electrochemical, optical, acoustic, and calorimetric types.
2.3.1.ElectrochemicalBiosensors. Electrochemicalbiosensors
aremainlyusedforthedetectionofhybridizedDNA,glucose
concentration, and so forth. Electrochemical biosensors can
be classified based on measurement of electrical parameters
such as: (i) conductometric, (ii) amperometric, and (iii)
potentiometric types. Electrochemical biosensors usually
contain three electrodes: a reference electrode, a working
e l e c t r o d e ,a n dac o u n t e re l e c t r o d e .Th er e a c t i o nf o rt a r g e t
analyte takes place on the active electrode surface. The
reactioncauseseitherelectrontransferacrossthedoublelayer
orcancontributetothedoublelayerpotential.Thesekindsof
b i o s e n s o r sa r eo ft e nm a d eb ys c r e e np r i n t i n gt h ee l e c t r o d e
patterns on a plastic substrate, coated with a conducting
polymer and then some protein is attached. All biosensors
usually involve minimal sample preparation as the biological
sensing component is highly selective and the signal is
produced by electrochemical and physical changes in the
conducting polymer layer.
2.3.2. Optical Biosensors. Optical biosensors are usually
made based on optical diffraction. These sensors can detect
microscopic changes when cells bind to receptors immobi-
lizedonthetransducersurface.Theyusethechangesinmass,
concentration, or number of molecules to direct changes
in characteristics of light. Researchers have used optical
techniques such as SPR and ellipsometry for the detection of
bacterial pathogens [29, 30].
2.3.3.OtherBiosensors:Acoustic,Thermometric,Magneticand
Piezoelectric Biosensors. The acoustic transducers used in
biosensors are based on either the bulk acoustic wave or the
surface acoustic wave. The transduction is through detection
of changes in their physiochemical properties, such as mass
density, elasticity, viscoelasticity, or electrical conductivity
[31]. Calorimetric transducers, on the other hand, depend
on changes in the temperature of the sensing site due to
biochemical reactions [32]. The thermometric, magnetic,
and piezoelectric transducers have failed so far to have any
practical impact on tissue engineering applications [33].
3. Applications of Biosensors in
Tissue Engineering
Biosensors can be of immense importance in tissue engi-
neering applications, particularly in maintaining three-
dimensional cell cultures [34] and developing “organs-on-
chips” models, where concentrations of biomolecules such
as glucose, adenosines, and hydrogen peroxide levels play
importantrolesindeterminingthefateofthecellsandtissues.
Living cells are well known to transmit various physical and
chemical signals, such as changes in consumption of oxygen,
pH, membrane potentials, ion concentrations, and release of
various metabolic compounds and proteins [35]. Monitoring
these analytes can give insights into cellular activities in real
time.
3.1. Detection of Small Molecules
3.1.1. Glucose. In clinical applications, biosensor-based mon-
itoring of blood glucose concentration has now become
a major diagnostic method to accurately trace diabetes
with high levels of glycated hemoglobin (HbA1c). In tissue
engineeringapplications,however,continuousmonitoringof
glucose in culture media is used as an indicator of metabolic
activities of cells [33, 36]. A number of different biosensing
approaches have been provided for glucose monitoring. This
includes electrochemical biosensors that are frequently used
for glucose oxidase or glucose dehydrogenase detection from
blood to interstitial fluids [37]. Several studies have reported
opticalbiosensorsforglucosedetectionusinginactiveapoen-
zymes,bindingproteins,andreceptors.Thisincludesalterna-
tive strategies and approaches for development of reversible,
implantable, and/or in-line sensing systems [38–40]. Inves-
tigations are also focused on discovering techniques to
m e a s u r et h eg l u c o s ec o n t e n tn o n i n v a s i v e l y .D e s p i t es o m e
promising improvements in the technology in recent years,
there is still no noninvasive tool that is in use in clinical
practice [41]. In the contrary, polarimetry [42, 43], diffuse
reflection spectroscopy [44, 45], absorption/transmission
spectroscopy [46, 47], thermal emission spectroscopy [48,
49], photoacoustic spectroscopy [50], and near-infrared
spectroscopy (NIRS) [51–53] have demonstrated promis-
ing successes in measuring blood glucose levels with highBioMed Research International 5
accuracy. The responsiveness of these methods, however, is
considerably slow due to the weak glucose absorption bands
(combination bands) and the presence of various undesired
bands from other constituents of the system. On the other
hand, the mid-infrared (MIR) region involves a prominent
g l u c o s ea b s o r p t i o nb a n da n di tg i v e si s o l a t e db a n di nh u m a n
blood [54–57]. However, MIR method is limited by strong
water absorption and background fluctuation that frequently
hampertheresults.Photoacoustic[50]andthermalradia tion
methods [47, 49] also demonstrate variable results for water
accumulation. Recently a noninvasive and noncontacting
technique, the wavelength modulated differential laser pho-
tothermal radiometry (WM-DPTR), has been developed for
continuous or intermittent glucose monitoring in the MIR
range. This can be applied to measure serum-glucose levels
in human skin in vitro [58, 59]. These recent advances in
application of nanobiosensor technologies in monitoring of
glucose concentrations are primarily targeted toward the
measurement of blood glucose level in diabetic patients [60].
Th e s et e c h n i q u e sc a nb ee q u a l l ya p p l i e dt om o n i t o rt h e
cellular metabolism in engineered tissue constructs in real
timeduringtheirfabrication,proliferation,andgrowth,given
thatconsumptionofglucosebythecellsisthebestindication
of cell metabolism [61].
3.1.2. Hydrogen Peroxide (H2O2). Accurate and reliable mea-
surement of H2O2 is of paramount importance in both
tissue engineering and clinical applications. The monitoring
of H2O2 allows detecting the presence of oxidative stress
or hypoxic conditions in the cell and tissue culture. Cur-
rently, available analytical methods of H2O2 measurement
includetechniquessuchaselectrochemistry,photometry,and
titration [62]. High (usually ≥50𝜇M) levels of H2O2 are
cytotoxic to human and to a wide range of animal, plant, and
bacterial cells. Abnormal level of H2O2 is highly detrimental
to the biological systems. In tissue engineering applications,
fluorescence-based and electrochemical methods have been
widely used for H2O2 detection. However, these techniques
have limitations including poor H2O2 specificity, low sensi-
tivity, difficulty in applying to the biological environments,
and invasiveness of measurement (e.g., electrode-based
method). Amperometric enzyme based biosensors have
gainedmuchattentionduetotheirrelativelyhighexpediency,
selectivity, and sensitivity [63, 64]. Development of sensitive
andsteadysensorsstemsfromtheefficientbindingofenzyme
to solid electrode surface [65]. Numerous strategies have
been developed to efficiently immobilize enzymes on the
electrode surface for H2O2 detection. These include, but are
not limited to, polymers [66, 67], quantum dots [68], and
various nanomaterials [69–71]. Among these, the nanomate-
rialsbasedmethodshavebeenthemostwidelyexploredones
for this purpose. For example, electrochemical biosensors
based on silver (Ag) nanoparticles(AgNPs) can be used as an
important component for the electrode. Xu et al. [72]d e v e l -
oped a H2O2 biosensor based on the direct electrochemistry
of hemoglobin (Hb) in Hb-Ag sol on glassy carbon (GC)
electrode. Hb showed a pair of distinct redox peaks on GC
electrodeandexhibitedhighsensibility,goodreproducibility,
andlong-termstability .N anoprobes,asapartofnanobiosen-
sors, are able to detect H2O2 using detection principles
(chemiluminescence,fluorescence,localizedsurfaceplasmon
resonance, near-infrared absorption, and electrochemical
methods), materials of nanoparticle matrix, and dependence
on enzymes [73–76]. The use of nanoprobes/sensors in H2O2
detection has certain advantages in both ex-vivo and in-vivo
tissue engineering. In general, nanoprobes are in the size
range of 10–500nm, which is much smaller than the size
of biological cells and this minimizes physical disturbance
to cells or tissues while performing measurements. Besides,
nanoprobes offer multifunctionalities and they can be made
tissue or cell specific by conjugating target-specific ligand
moieties onto the nanoparticle decorated electrode surface.
3.1.3. Adenosines. Extracellular adenosine diphosphate
(ADP) and adenosine triphosphate (ATP) are vital mul-
tifunctional molecules present in blood, heart, and liver.
Apart from its main role in cellular metabolism, ATP
i sn o wr e c o g n i z e da sa ni m p o r t a n te x t r a c e l l u l a rs i g -
naling agent. It can modulate a number of physiological
pathways by activating specific plasma membrane receptors.
Luciferase-basedmethodshavelongbeenusedformeasuring
adenosines; however, they have limited application in vivo
due to their low sensitivity and resolution. Consequently,
there is a need for alternative and more convenient methods
for ATP measurement. Biosensor can offer an option for in
situ extracellular ATP measurement and sensitive in vivo
applications [77, 78]. It is known that the extracellular ATP,
ADP, and uridine triphosphate (UTP) are involved in a wide
variety of different biological responses such as apoptosis,
cell proliferation, migration and differentiation, cytokine
release, and necrosis [79]. Nucleotide signaling participates
in several critical physiological and pathological events
such as immune system maturation, neurodegeneration,
inflammation, and cancer [80]. The in vivo extracellular ATP
concentration can increase to reach the hundred micromolar
level in many diseases such as hypoxia, trauma, ischemia,
cancer, or inflammation [81]. In general, extracellular ATP
is measured in the cell supernatant by using the standard
bioluminescence luciferin/luciferase assay. However, this
method does not permit real-time measurement of the
extracellular ATP concentration. Llaudet and coworkers
developed a microelectrode recording system for in
vivo measurements of ATP [77]; however, their method
requires the electrode to be placed inside the tissue which
may affect the ATP measurement. Another group used
a microelectrode biosensor to measure the purine in
granule primary cell culture for neuronal regeneration
[82]. Schneider and coworkers engineered a scanning tip,
coated with the ATPase-containing S1 myosin fragment, to
identify the sources of ATP release and to measure the ATP
concentration [83]. However, this method is complicated
for clinical applications. Hayashi and coworkers developed a
biosensor [84], which can be placed near the ATP-releasing
target cells. This technique gives an accurate result of
the extracellular ATP concentration. Recently, Xie and
coworkers developed a novel localized surface Plasmon6 BioMed Research International
resonance (LSPR) array chip for facile, label-free, and high
throughput detection of ATP using a normal microplate
reader. The report suggested that the developed LSPR sensor
c h i pc a nb eu s e df o rm i n i a t u r i z e da n dh i g ht h r o u g h p u t
detection of biological samples in tissue engineering
applications [85].
3.2.DetectionofFunctionalProteinMolecules. It is important
tomeasuretheactivitiesoffunctionalproteinmoleculessuch
asbioenzymesreleasedfromcells,underdifferentmicroenvi-
ronmental conditions to understand the fundamentals of cell
biology for therapeutic, diagnostic, and tissue engineering
applications.Matrixmetalloproteinase(MMPs),amemberof
proteinases family, is released by cells as a biological response
to their natural tissue remodeling processes [86]. MMPs are
alsoreleasedtovariousextentsinresponsetodifferentpatho-
logical conditionsincluding cancer [87]. Thus MMP proteins
can act as biomarkers for different diseased states which can
be detected and quantified with the help of biosensors. At
present, colorimetric methods with commercially available
proteinase assay kits are used to measure proteinase activity
[88]. Enzyme-responsive polymers are also popular as sens-
ing elements in biological devices [89–91]. In these cases,
fluorescent molecules are connected to a quencher through
p e p t i d es e q u e n c e sa n dc l e a v a g eo ft h ep e p t i d es e q u e n c e sb y
proteinase enzymes gives a fluorescence signal which can be
quantified to monitor the target protein concentration and
activities[92].Nevertheless,sometimethelabelingmethodis
not suitable, especially in detecting suboptimal biomolecule
levels in 3D in vitro tissue culture conditions. Recently, label-
free biosensors have been developed based on sensitive opti-
calbiosensingmethods[93,94].Suchbiosensorsexhibitreal-
time monitoring of abnormalities of extracellular proteins,
such as autophagy and proteostasis [95, 96]a sw e l la sin vitro
cell culture conditions [97]. Biophotonics based biosensors
canalsobeusedtomo ni to rthelevelo fextracell ularp r o teins,
hormones, and soluble molecules.
Biosensors have been used for early detection of cancer
biomarkers from blood samples in a noninvasive man-
ner. Surface plasmon resonance (SPR) and electrochemical
biosensors have been successfully used for the detection
of carcinoembryonic antigen (CEA) biomarkers for early
diagnosisoflungcancer inserum[98–100]. Lab-on-chipand
optical biosensors have been used for detection of epidermal
growth factor receptor (EGFR) biomarker for early diagnosis
ofcancer[101,102].Inengineeredtumormodels,fluorescence
basedbiosensorsrepresentusefultoolsfortheearlydetection
of biomarkers in clinical diagnostics, for monitoring disease
progression and response to treatment/therapeutics [103–
105]. Protein kinases are major proteins in cell signaling
pathways and disease progression and can act as real-time
biomarkers in response to different therapeutics which can
also be detected using biosensors [106–108]. The normal
ranges of many biomarkers are at nanogram and picogram
levelsandthesetraceamountscanonlybedetectedviahighly
sensitivebiosensingsystemswithpropersurfacechemistries,
nanomaterials functionalization, and signal amplification
methodologies.Ontheotherhand,therearestillmanyobsta-
cles for determination of disease markers using biosensors
like the reflection between the sensing molecule and the
target,nonspecificbindinginthecaseofserumorrealpatient
samples, the small size of the target, and the effect of the
microfluidics systems of the sensors on the measurement
process. These issues are the major challenges in biosensor
systems and they need more investigation to be overcome.
3.3.DetectionofOtherAnalytes. Differenttypesofbiosensors
have been developed for detection of pathogenic microbes.
Amperometric biosensors have been developed for indirect
detection of E. coli and direct detection of Salmonella
[109, 110]. Members of the Enterobacteriaceae family can
be detected by Piezoelectric immunosensors [111]. Neisseria
meningitidis and Brucella melitensis are detectable by a light
addressablepotentiometricsensor[112].Endotoxinsarecom-
plex lipopolysaccharides (LPS) of outer cell wall of all Gram-
negative bacteria causing fever, multiorgan failure, septic
shock, sepsis, meningococcemia, and severe morbidities like
neurologic disability and hearing loss. It is essential to detect
endotoxinforqualitycontrolinbiologicalproducts,recombi-
nanttherapeuticproducts,medicaldevices,serologicalprod-
u c t s ,f o o d ,a n dw a t e rs e c u r i t y[ 29, 113]. E. coli endotoxin was
detected by biosensor using fluorescence technique, where
the lower limit of detection was 10ng/mL and detection time
was 30 seconds [114]. Endotoxin from Salmonella minnesota
was identified at 0.1ng/mL level using an amperometric
biosensor [115] and 0.1pg/mL level by a piezoelectric biosen-
sor [116]. The recognition and quantitation of viruses are
essential for a broad variety of applications from sanitation
and food production to diagnostics and therapeutics [117,
118]. Dengue virus has been effectively detected using optical
biosensor [119], human immune deficiency virus (HIV)
by SPR EIS biosensor [120, 121], and liver inflammation
caused by Hepatitis C virus by optical and quartz crystal
microbalance (QCM) biosensor [122, 123].
4. Recent Trends in Biosensors
4.1. Quantum Dots Based Optical Biosensors. Semiconductor
quantum dots (Qdots) are one of the most promising optical
imagingagentsforin vitro (biosensorsandchemicalsensors)
and in vivo (noninvasive imaging of deep tissues) diagnosis
of diseases due to their ultra-stability and excellent quantum
confinement effects [1, 7, 124, 125]. Qdots have a broad
excitation and narrow size (5–10nm in diameter) tunable
emission spectrum with narrow emission band width. These
unique properties facilitate the use of Qdots in a wide range
offieldssuchasbiology,biosensor,electronics,andsolarcells
[5–7].ThesurfacemodificationanddecorationofQdotshave
inspired the development of novel multimodal probes based
biosensors through linking with peptides, nucleic acids, or
targeting ligands. Since the fluorescence intensity of Qdots is
highly stable and sensitive, fluorescence transduction based
on chemical or physical interaction occurs on the surface
eitherthroughdirectphotoluminescentactivationorthrough
quenching [9, 10]. Qdots have been widely investigated forBioMed Research International 7
possibilities of sensing pH, ions, organic compounds, and
biomolecules (nucleic acids, protein, and enzymes), as well
as other molecules of biological interests (Figure 2(a))[ 11,
12, 15, 16]. While the toxic effects of some Qdots have
still remained as a concern [14], the recent advancements
in application of Qdots in tissue engineering to detect the
enzyme and biomolecules are significant achievements of
biosensing research.
4.2. Carbon Nanotube Based Biosensors. The unique chemi-
cal and physical properties of carbon nanotubes have intro-
duced many new and improved sensing devices. Early cancer
detection in in vitro systems is one of the most recent, attrac-
tive, and breakthrough inventions from carbon nanotube
based biosensors [126, 127]. The specific antibody coated
surface of carbon nanotubes could be used for detecting
proteinsandvirusesofinterest(Figure 2(b)).Thekeyinsights
of this invention are noticeable changes in the electrical
conductivity of the nanotubes when the distance between
t h ea n t i b o d ya n dp r o t e i nc h a n g e s .Th ec h a n g eo fd i s t a n c e
can be detected by an electrical meter. Carbon nanotubes
have been widely investigated for promising applications in
dehydrogenase, peroxidase and catalase, DNA, glucose, and
enzyme sensors [128]. Carbon nanotube-based electrochem-
ical transduction demonstrates substantial improvements in
theactivityofamperometricenzymeelectrodes,immunosen-
sors,andnucleic-acidsensingbiosensors[129].Theenhanced
performance and properties of carbon nanotubes can thus be
im po rta n tinti s s ueen gin eerin gt oo v er co m eth ecurr en tlim-
itations such as improving elasticity, flexibility, cell growth,
and cell patterning.
4.3. MEMS/NEMS Based Biosensors. The growing need for
miniaturization of biosensors has resulted in increased inter-
ests in microelectromechanical systems (MEMS) [130, 131],
nanoelectromechanical systems (NEMS), and microfluidic
or lab-on-a-chip systems based biosensors [13, 132]. Such
miniaturized systems offer more accurate, specific, sensitive,
cost-effective, and high performance biosensor devices [133].
The different methods that have been used in MEMS based
biosensors include optical, mechanical, magnetic, and elec-
trochemicaldetections(Figure 2(c)).Organicdyes,semicon-
ductor quantum dots, and other optical fluorescence probes
have been used in optical detection methods [134], while
conjugation of magnetic, paramagnetic or ferromagnetic
nanoparticles has been used in magnetic MEMS biosensors
[135]. Mechanical MEMS biosensors are designed based on
one of the two factors, namely, changes in surface stress
and changes in mass. Biochemical reaction and adsorption
of analytes on the cantilever result in changes of surface
stress. The electrochemical MEMS based biosensors use
amperometric,potentiometric,orconductometricdetection.
4.4. Graphene Based Biosensors. Graphene based biosensors
have attracted significant scientific and technological inter-
ests due to the outstanding characteristics of graphene, such
as low production cost, large specific surface area, good
biocompatibility, high electrical conductivity, and excellent
electrochemical stability [136–138]. The 2D structure of
graphenefavors𝜋-electronconjugationandmakesitssurface
available to other chemical species. Therefore, graphene is
emerging as a preferred choice for the fabrication of various
biosensor devices in tissue engineering [136, 139, 140].
4.4.1. Graphene Quantum Dots Based Biosensors. Graphene
derivatives, especially 0D graphene quantum dots (Gdots),
are photoluminescent materials derived from graphene or
carbon fibers [141–143]. Gdots possess very unique optical
properties in combination of quantum confinement and
zig-zag edge effects. The ultra nanosized Gdots with wide
range of excitation/emission spectrum are promising can-
didates for applications in electronic, photoluminescence,
electrochemical and electrochemiluminescence sensors fab-
rication for various chemical and biological analyses [144];
see Figure 2(d). Gdots are superior compared to other well-
known optical imaging agents such as organic dyes and
cadmiumbasedQdotsduetotheirhighphotostabilityagainst
photobleaching, blinking, biocompatibility, and low toxicity
[145, 146]. These unique properties enable the Gdots to
be used in electronic sensors, electrochemiluminescence
sensors, electrochemical sensors, and photoluminescence
sensors [147]. In electronic sensors, Gdots are mainly used
in single electron transistor based charge sensors, unlike the
extensive application of graphene in field effect transistors.
Several methodologies have been reported for synthesis of
blue, green, yellow, and red Gdots from graphene or carbon
fiber [141–143]. The colors of Gdots are related to the basic
factors such as size, shape, excitation, pH, band gap, degree
of oxidation, surface functionalization, and doping of S and
N.Theas-synthesizedGdotsareveryconvenientfordetecting
any positively charged ions (cationic) such as Ag
2+ and Fe
3+
through charge-to-charge interactions [148]. The tunable
size of Gdots can be used for ssDNA detection, enzyme
immobilization, and avian leukosis virus subgroup J (ALVs-
J) detection. Decoration of Gold (Au) on the planer surface
of Gdots offers a wide range and low detection limit for
detection of H2O2. A Gdot based electrochemiluminescence
sensor was investigated for detecting Cd
2+,c y s t e i n e ,a n d
ATP. Low cytotoxicity, low cost, excellent solubility, and ease
of labeling of Gdots are also attractive for application in
development of novel ECL biosensors.
4.4.2.GrapheneBasedGlucoseBiosensor. Theglucosebiosen-
sors, as mentioned in earlier section, can be used in tissue
engineeringforcontinuousmeasurementsofmetabolicactiv-
ities of cells. Graphene oxide (GO), the precursor material of
graphene, has been used as a novel highly efficient enzyme
electrode for the detection of glucose in phosphate buffer
salinesolution(PBS)[149, 150]. The amine functional groups
ofglucoseoxidase(GOD)werecovalentlyattachedtothecar-
boxylfunctionalgroupsofGO.Thedirectelectrochemistryof
GODimmobilizedwiththechemicallyderivedgraphenewas
investigated in detail [151, 152]. The GOD immobilized elec-
trode retained its native structure and catalytic activity with
effective direct electron transfer reaction rate constant. The
electrocatalytic activity of the chemically derived graphene8 BioMed Research International
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immobilized GOD toward glucose. Figure 3 is reproduced with permission from Elsevier [159].
sheets exhibited enhanced electrocatalytic activity towards
the detection of glucose in PBS. The designed electrodes
displayedexcellentsensitivity,selectivity,andreproducibility,
suggesting their possible use in the fabrication of low cost
glucose sensing devices.
Graphene-based nanocomposite materials have been
extensively used in the fabrication of glucose biosensor [153–
158]. Graphene/gold nanoparticle (AuNP)/Nafion nanocom-
posite biosensor showed typical catalytic oxidation response
toglucoseandtheresponsewasveryfastupontheadditionof
glucose[154].Thesensingefficiencyanddetectionlimitofthe
graphene-based glucose biosensors were found to increase
when silver nanoparticle (AgNP)/AuNP hybrid was used to
catalyze electrochemical reaction of GOD [155].
The long-term stability of the developed biosensor was
examined over 30 days and was found to be stable after
the immobilization of the electrode with GOD. Wu et al.
[156] showed that platinum nanoparticle (PtNP) decorated
graphene/chitosan nanocomposite film could be used for
the detection of glucose. The biosensor showed a wide
linear range with fast response and high sensitivity. How-
ever, the standard deviation and detection limit of the
graphene/chitosan nanocomposite biosensor were found to
decrease in absence of PtNP as reported by Kang et al.
[157]. Ionic liquid modified graphene electrodes exhibited
excellentresponsetime,<5s,andgoodsensitivity[158].Ionic
liquidfunctionalizedgraphene-basedglucosesensorretained
its sensitivity and selectivity after immersion in PBS at low
temperature for a few weeks. Liang et al. [153] showed the
glucose sensing efficiency of the electrochemically reduced
carboxyl graphene. The designed biosensor showed linear
response to glucose at moderate concentrations with a
d e t e c t i o nl i m i to f0 . 0 2 m M .Th e r e f o r e ,i ti ss e e nt h a tt h e
g r a p h e n e - b a s e dg l u c o s es e n s o r sa r eh i g h l ys e n s i t i v e ,s e l e c -
tive, and reproducible in nature. The schematic for a glucose
biosensor using sulfonated poly-ether-ether-ketone (SPEEK)
modified graphene is shown in Figure 3 [159]. The sensor
can successfully detect glucose (Figure 4(a))b o t hi na b s e n c e10 BioMed Research International
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and in presence of commonly existing interfering species
such as ascorbic acid (AA), uric acid (UA), and dopamine.
4.4.3.Graphene-BasedCholesterolBiosensor. Cholesteroland
its esters are the essential components found in the cell
membranes of all human and animal cells. The normal
cholesterol limit in human serum is in the range of 1.0–
2.2mM and its excessive accumulation in blood results in
fatal diseases. Gholivand and Khodadadian [160] prepared
cholesterol biosensor using graphene/ionic liquid modified
glassy carbon electrode. Cholesterol oxidase (ChOx) and
catalase (CAT) were immobilized to develop highly sensitive
amperometric cholesterol biosensor. The RSD was found to
be <5% and it showed good reproducibility with minimal
interference from AA and UA (Figure 4(b)). The effect of
PtNP on the biosensing efficiency of cholesterol based on
graphene electrode was also investigated in detail [161]. The
d e t e c t i o nl i m i tw a sf o u n dt ob e0 . 5n Mi na b s e n c eo fC h O x
or cholesterol esterase. These types of biosensors exhibited
excellent sensitivity and linear response for the detection of
cholesterol in physiological solutions (Figure 4(b)). The use
of this kind of biosensor for the detection of free cholesterol
e x h i b i t e dg r e a tp r o m i s ef o rt h eu s ei nin vitro measurements.
4.4.4. Graphene-Based Hydrogen Peroxide Biosensor. An o v e l
H2O2 biosensor was fabricated using graphene/Fe3O4-AuNP
and graphene/Fe3O4-AuNP nanocomposites coated with
horseradish peroxidase [162, 163]. The biosensor showed
excellent performance towards the detection of H2O2.Th e
linear response of the biosensor was in the range of 2.0 ×
10
−5 moles lit
−1 to 2.5 × 10
−3 moles lit
−1 with a detection
limitof1.2×10
−5mollit
−1.Thebiosensorwashighlysensitive,
disposable, low cost, and strong anti-interference suggesting
its utility as a reliable device for the detection of H2O2.
The sensitivity, selectivity, and detection limit of the
enzymatic electrode are impressive. However, these elec-
trodes suffer from the limitation of reproducibility, high
cost, and complexity in enzyme immobilization procedure.
The enzymatic electrodes are also very sensitive towards
t h ec h a n g ei np Ho ft h es o l u t i o n ,t e m p e r a t u r e ,a n dt o x i c
chemicals. In order to overcome these limitations, the use
of nonenzymatic biosensors in the detection of biomolecules
h a sb e e ni n t r o d u c e da sd i s c u s s e db e l o w .
4.4.5. Nonenzymatic Biosensors. Nonenzymatic detection of
biomolecules using graphene-based electrodes has attracted
significant attention due to its low fabrication cost, high
sensitivity, and long-term stability. Li et al. [164]s h o w e d
nonenzymaticdetectionofH2O2 usingGO/MnO2 nanocom-
posites. The biosensor showed a linear range of 5–600𝜇M
with a detection limit of 0.8𝜇M. The biosensor remained
unaffected by the common interfering chemical species
such as SO4
−2,C l
−,N O 3
−,C O 3
−2, and citric acid. Wang
et al. [165] showed that chemically derived graphene can
detect dopamine with a linear range from 5 to 200𝜇M
in a large excess of AA. The nanocomposite of chemically
derived graphene/chitosan/AuNP exhibited enhanced sen-
sitivity towards the detection of DA and UA [166]. Zhong
et al. [167] showed the effect of AgNP on the graphene
thin films for the nonenzymatic detection of H2O2.Th e
biosensor exhibited fast amperometric response time of <2s
and a good linear range with a detection limit of 3 ×
10
−6 M. A new type of chemically modified graphene was
used for the selective detection of dopamine [168]. The
s u r f a c eo fg r a p h e n ew a sp r e p a r e db yt h es i l a n i z a t i o no f
graphene with N-(trimethoxysilylpropyl) ethylenediamine
triacetic acid (EDTA-silane). Electrochemical detection of
dihydronicotinamide adenine dinucleotide (NADH) based
on graphene modified glassy carbon (GC) electrode was
explored by Zhu et al. [169]. The sensor exhibited very high
sensitivity due to the large amount of graphitic edges and
porous structure of graphene sheets. The detection limit of
the sensor was found to be 0.23𝜇Mw i t haR S Do f3 . 4 %
(Figure 4(c)).
DNA biosensor was fabricated using graphene/PANI
nanocompositefilms[170]. The synergisticeffect of graphene
and PANI improved the response of the electrode due to
fast electron transfer at the electrode surfaces. Gupta et al.
developed a highly sensitive and selective DNA biosensor
using GO/AuNP composites [171]. The immobilization of
the ss-DNA was confirmed from electrochemical impedance
spectroscopy (EIS) analysis. The charge transfer resistance
was found to increase with increasing the concentration of
DNA. In comparison to the graphene/PANI biosensor, the
detection limit and linear range were significantly improved
intheGO/AuNPbiosensor[172].Huangetal.demonstrateda
novelelectrochemicalbiosensorfortheselectiveandsensitive
detection of DNA using polydopamine graphene composite
[173].Thedetectionlimitandthelinearrangeofthebiosensor
have been found to be 3.2 × 10
−15Ma n d1 . 0× 10
−13 to 1.0
× 10
−8M, respectively. It also displayed high selectivity to
differentiate one-base mismatched DNA. Therefore, it is seen
that the graphene-based sensing system is facile, rapid, and
cost-effective for the selective detection of various DNA.
4.5. Microfluidics and Biosensors. In the development of
tissue engineered constructs, the need for reliable and sen-
sitive tools to assess the artificial tissue environment has
become vitally important. Such platforms require to be con-
stantlymonitoredintermsofvariousphysiologicallyrelevant
parameters to evaluate the functionality of the engineered
tissue constructs. Microfluidic systems are able to mimic
various signals that direct cell fate to create specific organ
constructsby precisecontrolofthechemicalandmechanical
stimuli at microscale [174]. Besides, microfluidic platforms
allow handling tiny volumes of fluids (from microliters to
nanoliters) in a high throughput automated manner and
integrate several functions (e.g., multiplexing capability or
possibility to carry out numerous reactions) in a single
portable device [175, 176]. All these factors have made the
microfluidicplatformshighlyattractivefortissueengineering
particularly for organs on chips applications or for in vitro
tissue models. In this context, the progress made towards
the development of biosensors for point-of-care (POC)
applications over the recent years can be highly beneficial
for the tissue engineering applications as well. POC devices12 BioMed Research International
a r ea n a l y t i c a lt o o l sr o u t i n e l yu s e di nc l i n i c a ll a b o r a t o r i e sa s
well as at the patient bedside and are intended to provide
ar e l i a b l er e s p o n s ei nas h o r tt i m e[ 177]. In recent years,
their range of application has been further expanded by
exploiting microfluidic technologies. Combining the POC
capabilities with microfluidic platforms is the key challenge
for researchers in tissue engineering, as many biomarkers
have to be monitored to assess the functionality of any tissue
engineered construct in vitro.
Recently, a number of studies have been reported on
the combination of biosensor capabilities in microfluidic
devices for tissue engineering. Weltin et al. presented a
multiparametric microphysiometry platform to monitor the
metabolism of T98G human brain cancer cells cultured in
dynamic flow conditions [178]. A glass-made microfluidic
device was employed to facilitate optical imaging and several
microfabricated biosensors were integrated in the cell cham-
b e ra sw e l la si nu p s t r e a ma n dd o w n s t r e a mc o m p a r t m e n t s .
The levels of pH, oxygen consumption, and the production
of cell metabolites (lactate and glucose) were monitored
by using external equipment (e.g., potentiostat). Similarly,
Hu et al. included a light-addressable potentiometric sensor
(LAPS) in a microfluidic system to monitor the metabolism
of human breast cancer cells in real time [179]. Microheaters
and micropumps were also integrated to these systems for
controlling the temperature and handling different fluids
[180]. Moreover, aiming to study the behavior of adherent
cells in tissue engineered constructs, impedance analysis is
often used. Cells were cultured on the surface of a micro-
fabricated electrode and were exposed to low-magnitude AC
voltage. The electrical impedance measured in the system
was correlated to various cell parameters such as number,
type, state, and migration of cells. This technique is reported
successfully in lab-made microfluidic systems [181–183]a s
well as in commercially available tissue culture plates (e.g.,
ECISCulturewareDisposableElectrodeArraysfromApplied
BioPhysics Inc.).
A rapid translation of successful biosensing technologies
to tissue engineering platforms is only at an early stage
due to several challenges that researchers have to face for a
proper integration in microfluidic systems [184]. Cell culture
media include a very complex mixture of molecules (small
molecules as well as complex molecules such as proteins and
nucleic acids), extremely different in size and concentration.
As a result, any biosensor has to be very accurate and
s e n s i t i v et od e t e c tt h ea n a l y t ea m o n gah u g ep o p u l a t i o no f
molecules. Considering the cell number into these systems,
usually extremely low when compared to static conventional
standard culture, the analytes can be produced at a very
low level. In addition, other problems can occur such as
surface biofouling at the biosensor level and nonspecific
adsorption of target biomolecules in compartments different
from the biosensor surface, leading to false response errors
and decreased sensitivity. Strategies like the use of PEG
of bovine serum albumin to passivate the surface of the
microfluidic circuit can affect the system (i.e., the tissue
engineered construct) in an unpredictable way and might be
avoided.
On one hand, POC systems often present several capa-
bilities in a single device, such as fluid handling, sample
preparation (concentration, washing, etc.), and the possi-
bility to perform different reactions for biochemical assays.
On the other hand, the miniaturization and integration in
microfluidic cell culture systems of these capabilities can be
very challenging from a fabrication and operational point of
view, although several attempts are reported [185, 186]. Most
of these systems are employed as end-point detection tools
wherethesampleisdiscardedaftertest.Thusabigchallengeis
their usein realtimewith nosample volumewasted, in order
toperformseveraltestswiththesame(verysmall)amountof
liquid.
5. Concluding Remarks and Future Directions
There has been a growing interest in biosensor research for
applications in tissue engineering. However, the progress
has remained limited. Even though numerous optical, elec-
trochemical, magnetic, acoustic, thermometric, and piezo-
electric sensors have been reported in the literature and,
often, are already available in the market, showing great
sensitivityandsensibility,themostsuccessfulamongthemin
tissueengineeringapplicationshavebeentheelectrochemical
and optical ones, while the thermometric and magnetic
transductions have failed to have any practical impact. The
challenges forwidespread applicationsofbiosensorsin tissue
engineering include their miniaturization and integration in
microfluidic systems. The continuous real time monitoring
of analytes in tissue engineering is still at an early stage and
can bring enormous possibilities in the field. The creation
of microfluidic tissue engineering platforms with automated,
sensitive, and real-time monitoring capabilities will hugely
benefit the translation of such systems to clinics, as the full
assessment of their parameters is a must for clinical applica-
tions. The successful widespread application of biosensors in
tissue engineering particularly on microfluidic platforms will
require standardization of the systems and the processes.
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